Publique en esta revista
Información de la revista
Vol. 65. Núm. 2.
Páginas 172 (Febrero 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 65. Núm. 2.
Páginas 172 (Febrero 2012)
DOI: 10.1016/j.recesp.2011.11.007
Acceso a texto completo
Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases
Visitas
...
Michel Tenderaa, Victor Aboyansa, Marie-Louise Bartelinka, Iris Baumgartnera, Denis Clémenta, Jean-Philippe Colleta, Alberto Cremonesia, Marco De Carloa, Raimund Erbela, F. Gerry R. Fowkesa, Magda Herasa, Serge Kownatora, Erich Minara, Jan Ostergrena, Don Poldermansa, Vincent Riambaua, Marco Roffia, Joachim Röthera, Horst Sieverta, Marc van Sambeeka, Thomas Zellera
Contenido relaccionado
Rev Esp Cardiol. 2012;65:119-2410.1016/j.recesp.2011.12.002
Ángel Cequier, César Carrascosa, Exuperio Diez-Tejedor, Marian Goicoechea, Alejandro González-García, Juan Quiles, Rafael Ruiz-Salmerón, Vicenç Riambau, Ángel M. Alonso Gómez, Manuel Anguita, Josep Comín, Antonio Fernández-Ortiz, Manuel Pan, Fernando Worner
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Steg PG, Bhatt DL, Wilson PW, D’Agostino R, Ohman EM, Rother J, et-al..
Oneyear cardiovascular event rates in outpatients with atherothrombosis..
JAMA. , 297 (2007), pp. 1197-1206
[2]
Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et-al..
Mortality over a period of 10 years in patients with peripheral arterial disease..
N Engl J Med. , 326 (1992), pp. 381-386
[3]
Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et-al..
A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences..
J Vasc Surg. , 45 (2007), pp. 1185-1191
[4]
Kroger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A, et-al..
Prevalence of peripheral arterial disease —results of the Heinz Nixdorf recall study..
Eur J Epidemiol. , 21 (2006), pp. 279-285
[5]
Kannel WB, McGee DL..
Update on some epidemiologic features of intermittent claudication: the Framingham Study..
J Am Geriatr Soc. , 33 (1985), pp. 13-18
[6]
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR..
Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II)..
J Vasc Surg. , 45 (2007), pp. S5-S67
[7]
Ingolfsson IO, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N..
A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol—the Reykjavik Study..
J Clin Epidemiol. , 47 (1994), pp. 1237-1243
[8]
Murabito JM, Evans JC, D’Agostino RB, Wilson PW, Kannel WB..
Temporal trends in the incidence of intermittent claudication from 1950 to 1999..
Am J Epidemiol. , 162 (2005), pp. 430-437
[9]
Bots ML, Breslau PJ, Briet E, De Bruyn AM, Van Vliet HH, Van den Ouweland FA, et-al..
Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study..
Hypertension. , 19 (1992), pp. 717-720
[10]
Mathiesen EB, Joakimsen O, Bonaa KH..
Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study..
Cerebrovasc Dis. , 12 (2001), pp. 44-51
[11]
O, Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, et-al..
Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study..
The CHS Collaborative Research Group, Stroke. , 23 (1992), pp. 1752-1760
[12]
Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, et-al..
Prevalence of renovascular disease in the elderly: a population-based study..
J Vasc Surg. , 36 (2002), pp. 443-451
[13]
De Mast Q, Beutler JJ..
The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review..
J Hypertens. , 27 (2009), pp. 1333-1340
[14]
Valentine RJ, Martin JD, Myers SI, Rossi MB, Clagett GP..
Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses..
J Vasc Surg. , 14 (1991), pp. 195-199
[15]
Shadman R, Criqui MH, Bundens WP, Fronek A, Denenberg JO, Gamst AC, et-al..
Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases..
J Am Coll Cardiol. , 44 (2004), pp. 618-623
[16]
Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, et-al..
Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study..
Am J Epidemiol. , 135 (1992), pp. 331-340
[17]
Criqui MH..
Peripheral arterial disease —epidemiological aspects..
Vasc Med. , 6 (2001), pp. 3-7
[18]
Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA..
The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease..
Int J Epidemiol. , 25 (1996), pp. 282-290
[19]
Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE..
Peripheral arterial disease in the elderly: the Rotterdam Study..
Arterioscler Thromb Vasc Biol. , 18 (1998), pp. 185-192
[20]
Ridker PM, Stampfer MJ, Rifai N..
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease..
JAMA. , 285 (2001), pp. 2481-2485
[21]
Chrysochou C, Kalra PA..
Epidemiology and natural history of atherosclerotic renovascular disease..
Prog Cardiovasc Dis. , 52 (2009), pp. 184-195
[22]
English JA, Carell ES, Guidera SA, Tripp HF..
Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization..
Catheter Cardiovasc Interv. , 54 (2001), pp. 8-11
[23]
Pickett CA, Jackson JL, Hemann BA, Atwood JE..
Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis..
Lancet. , 371 (2008), pp. 1587-1594
[24]
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et-al..
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)..
Eur Heart J. , 28 (2007), pp. 2375-2414
[25]
Reiner Z, Catapano A, De Backer G, Graham I, Taskinen MR, Wiklund O, et-al..
ESC/EAS Guidelines for the managemeint of dyslipidaemias..
Eur Heart J. , 32 (2011), pp. 1769-1818
[26]
Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, et-al..
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial..
JAMA. , 303 (2010), pp. 841-848
[27]
Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et-al..
The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis)..
J Am Coll Cardiol. , 56 (2010), pp. 1506-1512
[28]
Ruehm SG, Goyen M, Barkhausen J, Kroger K, Bosk S, Ladd ME, et-al..
Rapid magnetic resonance angiography for detection of atherosclerosis..
Lancet. , 357 (2001), pp. 1086-1091
[29]
Goyen M, Quick HH, Debatin JF, Ladd ME, Barkhausen J, Herborn CU, et-al..
Wholebody three-dimensional MR angiography with a rolling table platform: initial clinical experience..
Radiology. , 224 (2002), pp. 270-277
[30]
Gohde SC, Goyen M, Forsting M, Debatin JF..
Prevention without radiation— a strategy for comprehensive early detection using magnetic resonance tomography]..
Radiologe. , 42 (2002), pp. 622-629
[31]
Fenchel M, Scheule AM, Stauder NI, Kramer U, Tomaschko K, Nagele T, et-al..
Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results..
Radiology. , 238 (2006), pp. 280-291
[32]
Fowler B, Jamrozik K, Norman P, Allen Y..
Prevalence of peripheral arterial disease: persistence of excess risk in former smokers..
Aust N Z J Public Health. , 26 (2002), pp. 219-224
[33]
Smith FB, Lowe GD, Lee AJ, Rumley A, Leng GC, Fowkes FG..
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication..
J Vasc Surg. , 28 (1998), pp. 129-135
[34]
Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, et-al..
Triple-combination pharmacotherapy for medically ill smokers: a randomized trial..
Ann Intern Med. , 150 (2009), pp. 447-454
[35]
Aboyans V, Thomas D, Lacroix P..
The cardiologist and smoking cessation..
Curr Opin Cardiol. , 25 (2010), pp. 469-477
[36]
Collins R, Armitage J, Parish S, Sleigh P, Peto R..
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial..
Lancet. , 361 (2003), pp. 2005-2016
[37]
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et-al..
Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials..
Lancet. , 373 (2009), pp. 1849-1860
[38]
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348:1329-39..
[39]
Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et-al..
CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events..
N Engl J Med. , 354 (2006), pp. 1706-1717
[40]
Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA..
Patients with peripheral arterial disease in the CHARISMA trial..
Eur Heart J. , 30 (2009), pp. 192-201
[41]
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et-al..
The task force for the management of arterial hypertension of the European Society of Hypertension.The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)..
Eur Heart J. , 28 (2007), pp. 1462-1536
[42]
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et-al..
European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document..
J Hypertens. , 27 (2009), pp. 2121-2158
[43]
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G..
Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators..
N Engl J Med. , 342 (2000), pp. 145-153
[44]
Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et-al..
Telmisartan, ramipril, or both in patients at high risk for vascular events..
N Engl J Med. , 358 (2008), pp. 1547-1559
[45]
Radack K, Deck C..
Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials..
Arch Intern Med. , 151 (1991), pp. 1769-1776
[46]
Aronow WS, Ahn C..
Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease..
Am J Cardiol. , 87 (2001), pp. 1284-1286
[47]
Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et-al..
Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA)..
Eur Heart J. , 30 (2009), pp. 2769-2812
[48]
Hobbs SD, Bradbury AW..
Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach..
Eur J Vasc Endovasc Surg. , 26 (2003), pp. 341-347
[49]
Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et-al..
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank..
Stroke. , 32 (2001), pp. 2559-2566
[50]
Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et-al..
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators..
N Engl J Med. , 339 (1998), pp. 1415-1425
[51]
European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351:1379-87..
[52]
Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE, et-al..
The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators..
N Engl J Med. , 342 (2000), pp. 1693-1700
[53]
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273:1421-8..
[54]
Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et-al..
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial..
Lancet. , 363 (2004), pp. 1491-1502
[55]
Abbott AL..
Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis..
Stroke. , 40 (2009), pp. e573-e583
[56]
Schneider PA, Naylor AR..
Transatlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting..
Eur J Vasc Endovasc Surg. , 40 (2010), pp. 274-281
[57]
Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et-al..
A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack..
[58]
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003; 229:340-6..
[59]
Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess. 2006; 10:iii-iv, ix-x, 1-182..
[60]
Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M, Rudolph AE, et-al..
High-dose atorvastatin after stroke or transient ischemic attack..
N Engl J Med. , 355 (2006), pp. 549-559
[61]
Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, et-al..
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial..
Stroke. , 39 (2008), pp. 3297-3302
[62]
Bond R, Rerkasem K, AbuRahma AF, Naylor AR, Rothwell PM..
Patch angioplasty versus primary closure for carotid endarterectomy..
Cochrane Database Syst Rev. , (2004), pp. CD000160
[63]
Mannheim D, Weller B, Vahadim E, Karmeli R..
Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study..
J Vasc Surg. , 41 (2005), pp. 403-407
[64]
Cao PG, De Rango P, Zannetti S, Giordano G, Ricci S, Celani MG..
Eversion versus conventional carotid endarterectomy for preventing stroke..
Cochrane Database Syst Rev. , (2001), pp. CD001921
[65]
Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D, et-al..
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial..
Lancet. , 372 (2008), pp. 2132-2142
[66]
Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et-al..
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial..
Lancet. , 376 (2010), pp. 1074-1084
[67]
McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS..
The benefits of combined anti-platelet treatment in carotid artery stenting..
Eur J Vasc Endovasc Surg. , 29 (2005), pp. 522-527
[68]
Dalainas I, Nano G, Bianchi P, Stegher S, Malacrida G, Tealdi DG..
Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting..
Cardiovasc Intervent Radiol. , 29 (2006), pp. 519-521
[69]
Roffi M, Sievert H, GrayWA, White CJ, Torsello G, Cao P, et-al..
Carotid artery stenting versus surgery: adequate comparisons?..
Lancet Neurol. , 9 (2010), pp. 339-341
[70]
Barbato JE, Dillavou E, Horowitz MB, Jovin TG, Kanal E, David S, et-al..
A randomized trial of carotid artery stenting with and without cerebral protection..
J Vasc Surg. , 47 (2008), pp. 760-765
[71]
Macdonald S, Evans DH, Griffiths PD, McKevitt FM, Venables GS, Cleveland TJ, et-al..
Filter-protected versus unprotected carotid artery stenting: a randomised trial..
Cerebrovasc Dis. , 29 (2010), pp. 282-289
[72]
Kastrup A, Nagele T, Groschel K, Schmidt F, Vogler E, Schulz J, et-al..
Incidence of new brain lesions after carotid stenting with and without cerebral protection..
[73]
Garg N, Karagiorgos N, Pisimisis GT, Sohal DP, Longo GM, Johanning JM, et-al..
Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature..
J Endovasc Ther. , 16 (2009), pp. 412-427
[74]
Zahn R, Mark B, Niedermaier N, Zeymer U, Limbourg P, Ischinger T, et-al..
Embolic protection devices for carotid artery stenting: better results than stenting without protection?..
Eur Heart J. , 25 (2004), pp. 1550-1558
[75]
Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F..
Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients..
[76]
Jansen O, Fiehler J, Hartmann M, Bruckmann H..
Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial..
Stroke. , 40 (2009), pp. 841-846
[77]
Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, et-al..
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS)..
Lancet Neurol. , 9 (2010), pp. 353-362
[78]
Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, et-al..
Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients..
Catheter Cardiovasc Interv. , 73 (2009), pp. 129-136
[79]
Brott TG, Hobson RW, 2nd, Howard G, Roubin GS, Clark WM, Brooks W, et-al..
Stenting versus endarterectomy for treatment of carotid-artery stenosis..
N Engl J Med. , 363 (2010), pp. 11-23
[80]
Stabile E, Salemme L, Sorropago G, Tesorio T, Nammas W, Miranda M, et-al..
Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients..
J Am Coll Cardiol. , 55 (2010), pp. 1661-1667
[81]
Hobson RW 2nd, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328:221-7..
[82]
Roffi M, Mukherjee D, Clair DG..
Carotid artery stenting vs. endarterectomy..
Eur Heart J. , 30 (2009), pp. 2693-2704
[83]
Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, et-al..
The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting..
Catheter Cardiovasc Interv. , 69 (2007), pp. 341-348
[84]
Katzen BT, Criado FJ, Ramee SR, Massop DW, Hopkins LN, Donohoe D, et-al..
Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study..
Catheter Cardiovasc Interv. , 70 (2007), pp. 316-323
[85]
Theiss W, Hermanek P, Mathias K, Ahmadi R, Heuser L, Hoffmann FJ, et-al..
Pro- CAS: a prospective registry of carotid angioplasty and stenting..
[86]
Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML, Sicard GA..
Riskadjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry..
J Vasc Surg. , 49 (2009), pp. 71-79
[87]
GrayWA, Chaturvedi S, Verta P..
Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries..
Circ Cardiovasc Interv. , 2 (2009), pp. 159-166
[88]
Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et-al..
Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison..
Lancet. , 370 (2007), pp. 1432-1442
[89]
Luengo-Fernandez R, Gray AM, Rothwell PM..
Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison..
Lancet Neurol. , 8 (2009), pp. 235-243
[90]
Naylor AR..
The importance of initiating ‘best medical therapy’ and intervening as soon as possible in patients with symptomatic carotid artery disease: time for a radical rethink of practice..
J Cardiovasc Surg (Torino). , 50 (2009), pp. 773-782
[91]
Mayberg MR, Wilson SE, Yatsu F, Weiss DG, Messina L, Hershey LA, et-al..
Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group..
JAMA. , 266 (1991), pp. 3289-3294
[92]
Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et-al..
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis..
Lancet. , 361 (2003), pp. 107-116
[93]
Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ..
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery..
Lancet. , 363 (2004), pp. 915-924
[94]
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357:1729-37..
[95]
Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et-al..
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis..
N Engl J Med. , 355 (2006), pp. 1660-1671
[96]
Ederle J, Dobson J, Featherstone RL, Bonati LH, Van der Worp HB, De Borst GJ, et-al..
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial..
Lancet. , 375 (2010), pp. 985-997
[97]
Fiehler J, Jansen O, Berger J, Eckstein HH, Ringleb PA, Stingele R..
Differences in complication rates among the centres in the SPACE study..
Neuroradiology. , 50 (2008), pp. 1049-1053
[98]
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et-al..
Protected carotid-artery stenting versus endarterectomy in high-risk patients..
N Engl J Med. , 351 (2004), pp. 1493-1501
[99]
Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et-al..
Long-term results of carotid stenting versus endarterectomy in high-risk patients..
N Engl J Med. , 358 (2008), pp. 1572-1579
[100]
Ederle J, Bonati LH, Dobson J, Featherstone RL, Gaines PA, Beard JD, et-al..
Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial..
Lancet Neurol. , 8 (2009), pp. 898-907
[101]
Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, Hartmann M, et-al..
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial..
Lancet. , 368 (2006), pp. 1239-1247
[102]
Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, et-al..
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial..
Lancet Neurol. , 7 (2008), pp. 893-902
[103]
Mas JL, Chatellier G, Beyssen B..
Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial..
[104]
Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, et-al..
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial..
Lancet Neurol. , 7 (2008), pp. 885-892
[105]
Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C..
Carotid artery stenting versus carotid endarterectomy: a comprehensive metaanalysis of short-term and long-term outcomes..
Stroke. , 42 (2011), pp. 687-692
[106]
Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM..
Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study..
Brain. , 132 (2009), pp. 982-988
[107]
Bogousslavsky J, Van Melle G, Regli F..
The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke..
Stroke. , 19 (1988), pp. 1083-1092
[108]
Bogousslavsky J, Regli F..
Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications..
Ann Neurol. , 20 (1986), pp. 346-350
[109]
Wityk RJ, Chang HM, Rosengart A, Han WC, DeWitt LD, Pessin MS, et-al..
Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry..
Arch Neurol. , 55 (1998), pp. 470-478
[110]
Caplan LR, Wityk RJ, Glass TA, Tapia J, Pazdera L, Chang HM, et-al..
New England Medical Center Posterior Circulation registry..
Ann Neurol. , 56 (2004), pp. 389-398
[111]
Khan S, Cloud GC, Kerry S, Markus HS..
Imaging of vertebral artery stenosis: a systematic review..
J Neurol Neurosurg Psychiatry. , 78 (2007), pp. 1218-1225
[112]
Berguer R, Flynn LM, Kline RA, Caplan L..
Surgical reconstruction of the extracranial vertebral artery: management and outcome..
J Vasc Surg. , 31 (2000), pp. 9-18
[113]
Aboyans V, Criqui MH, McDermott MM, Allison MA, Denenberg JO, Shadman R, et-al..
The vital prognosis of subclavian stenosis..
J Am Coll Cardiol. , 49 (2007), pp. 1540-1545
[114]
Sixt S, Rastan A, Schwarzwalder U, Burgelin K, Noory E, Schwarz T, et-al..
Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction..
Catheter Cardiovasc Interv. , 73 (2009), pp. 395-403
[115]
De Vries JP, Jager LC, Van den Berg JC, Overtoom TT, Ackerstaff RG, Van de Pavoordt ED, et-al..
Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results..
J Vasc Surg. , 41 (2005), pp. 19-23
[116]
Cina CS, Safar HA, Lagana A, Arena G, Clase CM..
Subclavian carotid transposition and bypass grafting: consecutive cohort study and systematic review..
J Vasc Surg. , 35 (2002), pp. 422-429
[117]
Hughes K, Hamdan A, Schermerhorn M, Giordano A, Scovell S, Pomposelli F..
Bypass for chronic ischemia of the upper extremity: results in 20 patients..
J Vasc Surg. , 46 (2007), pp. 303-307
[118]
Bakken AM, Palchik E, Saad WE, Hart JP, Singh MJ, Rhodes JM, et-al..
Outcomes of endoluminal therapy for ostial disease of the major branches of the aortic arch..
Ann Vasc Surg. , 22 (2008), pp. 388-394
[119]
Lee AD, Agarwal S, Sadhu D..
A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia..
World J Surg. , 30 (2006), pp. 1644-1647
[120]
Thomas JH, Blake K, Pierce GE, Hermreck AS, Seigel E..
The clinical course of asymptomatic mesenteric arterial stenosis..
J Vasc Surg. , 27 (1998), pp. 840-844
[121]
Van Bockel JH, Geelkerken RH, Wasser MN..
Chronic splanchnic ischaemia..
Best Pract Res Clin Gastroenterol. , 15 (2001), pp. 99-119
[122]
Babu SC, Shah PM..
Celiac territory ischemic syndrome in visceral artery occlusion..
Am J Surg. , 166 (1993), pp. 227-230
[123]
Liberski SM, Koch KL, Atnip RG, Stern RM..
Ischemic gastroparesis: resolution after revascularization..
Gastroenterology. , 99 (1990), pp. 252-257
[124]
Taylor LM, Moneta GL..
Intestinal ischemia..
Ann Vasc Surg. , 5 (1991), pp. 403-406
[125]
Ghosh S, Roberts N, Firmin RK, Jameson J, Spyt TJ..
Risk factors for intestinal ischaemia in cardiac surgical patients..
Eur J Cardiothorac Surg. , 21 (2002), pp. 411-416
[126]
Wilson DB, Mostafavi K, Craven TE, Ayerdi J, Edwards MS, Hansen KJ..
Clinical course of mesenteric artery stenosis in elderly Americans..
Arch Intern Med. , 166 (2006), pp. 2095-2100
[127]
Mensink PB, Van Petersen AS, Geelkerken RH, Otte JA, Huisman AB, Kolkman JJ..
Clinical significance of splanchnic artery stenosis..
Br J Surg. , 93 (2006), pp. 1377-1382
[128]
Moawad J, Gewertz BL..
Chronic mesenteric ischemia. Clinical presentation and diagnosis..
Surg Clin North Am. , 77 (1997), pp. 357-369
[129]
Pellerito JS, Revzin MV, Tsang JC, Greben CR, Naidich JB..
Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis..
J Ultrasound Med. , 28 (2009), pp. 641-650
[130]
Moneta GL, Lee RW, Yeager RA, Taylor LM, Porter JM..
Mesenteric duplex scanning: a blinded prospective study..
J Vasc Surg. , 17 (1993), pp. 79-84
[131]
Armstrong PA..
Visceral duplex scanning: evaluation before and after artery intervention for chronic mesenteric ischemia..
Perspect Vasc Surg Endovasc Ther. , 19 (2007), pp. 386-392
[132]
Dietrich CF, Jedrzejczyk M, Ignee A..
Sonographic assessment of splanchnic arteries and the bowel wall..
Eur J Radiol. , 64 (2007), pp. 202-212
[133]
Zwolak RM..
Can duplex ultrasound replace arteriography in screening for mesenteric ischemia?..
Semin Vasc Surg. , 12 (1999), pp. 252-260
[134]
Cademartiri F, Palumbo A, Maffei E, Martini C, Malago R, Belgrano M, et-al..
Noninvasive evaluation of the celiac trunk and superior mesenteric artery with multislice CT in patients with chronic mesenteric ischaemia..
Radiol Med. , 113 (2008), pp. 1135-1142
[135]
Horton KM, Fishman EK, Multidetector CT..
angiography in the diagnosis of mesenteric ischemia..
Radiol Clin North Am. , 45 (2007), pp. 275-288
[136]
Hellinger JC..
Evaluating mesenteric ischemia with multidetector-row CT angiography..
Tech Vasc Interv Radiol. , 7 (2004), pp. 160-166
[137]
Laghi A, Iannaccone R, Catalano C, Passariello R..
Multislice spiral computed tomography angiography of mesenteric arteries..
Lancet. , 358 (2001), pp. 638-639
[138]
Otte JA, Huisman AB, Geelkerken RH, Kolkman JJ..
Jejunal tonometry for the diagnosis of gastrointestinal ischemia. Feasibility, normal values and comparison of jejunal with gastric tonometry exercise testing..
Eur J Gastroenterol Hepatol. , 20 (2008), pp. 62-67
[139]
Cleveland TJ, Nawaz S, Gaines PA..
Mesenteric arterial ischaemia: diagnosis and therapeutic options..
Vasc Med. , 7 (2002), pp. 311-321
[140]
Cognet F, Ben Salem D, Dranssart M, Cercueil JP, Weiller M, Tatou E, et-al..
Chronic mesenteric ischemia: imaging and percutaneous treatment..
Radiographics. , 22 (2002), pp. 863-879
[141]
Laissy JP, Trillaud H, Douek P..
MR angiography: noninvasive vascular imaging of the abdomen..
Abdom Imaging. , 27 (2002), pp. 488-506
[142]
Schermerhorn ML, Giles KA, Hamdan AD, Wyers MC, Pomposelli FB..
Mesenteric revascularization: management and outcomes in the United States, 1988-2006..
J Vasc Surg. , 50 (2009), pp. 341-348
[143]
Davies RS, Wall ML, Silverman SH, Simms MH, Vohra RK, Bradbury AW, et-al..
Surgical versus endovascular reconstruction for chronic mesenteric ischemia: a contemporary UK series..
Vasc Endovascular Surg. , 43 (2009), pp. 157-164
[144]
Lee RW, Bakken AM, Palchik E, Saad WE, Davies MG..
Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease..
Ann Vasc Surg. , 22 (2008), pp. 541-546
[145]
Zerbib P, Lebuffe G, Sergent-Baudson G, Chamatan A, Massouille D, Lions C, et-al..
Endovascular versus open revascularization for chronic mesenteric ischemia: a comparative study..
Langenbecks Arch Surg. , 393 (2008), pp. 865-870
[146]
AbuRahma AF, Stone PA, Bates MC, Welch CA..
Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes..
[147]
Zeller T, Rastan A, Schwarzwalder U, Schwarz T, Frank U, Burgelin K, et-al..
Endovascular therapy of chronic mesenteric ischaemia..
EuroIntervention. , 2 (2007), pp. 444-451
[148]
Schaefer PJ, Schaefer FK, Hinrichsen H, Jahnke T, Charalambous N, Heller M, et-al..
Stent placement with the monorail technique for treatment of mesenteric artery stenosis..
J Vasc Interv Radiol. , 17 (2006), pp. 637-643
[149]
Mell MW, Acher CW, Hoch JR, Tefera G, Turnipseed WD..
Outcomes after endarterectomy for chronic mesenteric ischemia..
J Vasc Surg. , 48 (2008), pp. 1132-1138
[150]
Biebl M, Oldenburg WA, Paz-Fumagalli R, McKinney JM, Hakaim AG..
Surgical and interventional visceral revascularization for the treatment of chronic mesenteric ischemia—when to prefer which?..
World J Surg. , 31 (2007), pp. 562-568
[151]
Safian RD, Textor SC, Renal-artery stenosis, Engl..
Med. , 344 (2001), pp. 431-442
[152]
Neymark E, LaBerge JM, Hirose R, Melzer JS, Kerlan RK, Wilson MW, et-al..
Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery..
Radiology. , 214 (2000), pp. 755-760
[153]
De Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, Bartunek J, et-al..
Assessment of renal artery stenosis severity by pressure gradient measurements..
J Am Coll Cardiol. , 48 (2006), pp. 1851-1855
[154]
Rimmer JM, Gennari FJ..
Atherosclerotic renovascular disease and progressive renal failure..
Ann Intern Med. , 118 (1993), pp. 712-719
[155]
Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, et-al..
Risk of atrophy in kidneys with atherosclerotic renal artery stenosis..
Kidney Int. , 53 (1998), pp. 735-742
[156]
Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, et-al..
Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis..
Hypertension. , 55 (2010), pp. 961-966
[157]
Fatica RA, Port FK, Young EW..
Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States..
Am J Kidney Dis. , 37 (2001), pp. 1184-1190
[158]
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY..
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization..
N Engl J Med. , 351 (2004), pp. 1296-1305
[159]
Hostetter TH..
Chronic kidney disease predicts cardiovascular disease..
N Engl J Med. , 351 (2004), pp. 1344-1346
[160]
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP..
Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study..
Ann Intern Med. , 110 (1989), pp. 101-107
[161]
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP..
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study..
N Engl J Med. , 322 (1990), pp. 1561-1566
[162]
Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA..
Left ventricular morphology and function in patients with atherosclerotic renovascular disease..
J Am Soc Nephrol. , 16 (2005), pp. 2746-2753
[163]
Greco BA, Breyer JA..
The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?..
Semin Nephrol. , 16 (1996), pp. 2-11
[164]
Schreiber MJ, Pohl MA, Novick AC..
The natural history of atherosclerotic and fibrous renal artery disease..
Urol Clin North Am. , 11 (1984), pp. 383-392
[165]
Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE..
A prospective study of disease progression in patients with atherosclerotic renal artery stenosis..
Am J Hypertens. , 9 (1996), pp. 1055-1061
[166]
Jaarsveld van BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-14..
[167]
Connolly JO, Higgins RM, Walters HL, Mackie AD, Drury PL, Hendry BM, et-al..
Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease..
QJM. , 87 (1994), pp. 413-421
[168]
White CJ, Jaff MR, Haskal ZJ, Jones DJ, Olin JW, Rocha-Singh KJ, et-al..
Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization. Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease..
Circulation. , 114 (2006), pp. 1892-1895
[169]
Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, et-al..
Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements..
Eur Heart J. , 29 (2008), pp. 517-524
[170]
AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med. 2009; 28:120-14..
[171]
Zeller T, Bonvini RF, Sixt S..
Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization..
Catheter Cardiovasc Interv. , 71 (2008), pp. 995-999
[172]
Zeller T, Frank U, Spath M, Roskamm H..
[Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses]..
Ultraschall Med. , 22 (2001), pp. 116-121
[173]
Radermacher J, Weinkove R, Haller H..
Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease..
Curr Opin Nephrol Hypertens. , 10 (2001), pp. 799-805
[174]
Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, et al. Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-82..
[175]
Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R..
Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy..
J Am Coll Cardiol. , 53 (2009), pp. 1621-1628
[176]
Kapoor N, Fahsah I, Karim R, Jevans AJ, Leesar MA..
Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements..
Catheter Cardiovasc Interv. , 76 (2010), pp. 726-732
[177]
Mangiacapra F, Trana C, Sarno G, Davidavicius G, Protasiewicz M, Muller O, et-al..
Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension..
Circ Cardiovasc Interv. , 3 (2010), pp. 537-542
[178]
Jaarsveld van BC, Krijnen P, Derkx FH, Oei HY, Postma CT, Schalekamp MA..
The place of renal scintigraphy in the diagnosis of renal artery stenosis.Fifteen years of clinical experience..
Arch Intern Med. , 157 (1997), pp. 1226-1234
[179]
Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT..
Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience..
Am J Kidney Dis. , 24 (1994), pp. 622-629
[180]
Zeller T, Muller C, Frank U, Burgelin K, Schwarzwalder U, Horn B, et-al..
Survival after stenting of severe atherosclerotic ostial renal artery stenoses..
[181]
Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, et-al..
Angiotensin inhibition in renovascular disease: a population-based cohort study..
Am Heart J. , 156 (2008), pp. 549-555
[182]
Plouin PF..
Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management..
Am J Kidney Dis. , 42 (2003), pp. 851-857
[183]
Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Grou*p. J Hum Hypertens. 1998;12:329-35..
[184]
Nordmann AJ, Logan AG..
Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction..
Cochrane Database Syst Rev. , (2003), pp. CD002944
[185]
Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, et-al..
Effectiveness of management strategies for renal artery stenosis: a systematic review..
Ann Intern Med. , 145 (2006), pp. 901-912
[186]
Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM..
Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure..
Vasc Med. , 7 (2002), pp. 275-279
[187]
Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD..
Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis..
Nephrol Dial Transplant. , 25 (2010), pp. 813-820
[188]
Kalra PA..
Renal revascularization for heart failure in patients with atherosclerotic renovascular disease..
Nephrol Dial Transplant. , 25 (2010), pp. 661-663
[189]
Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-9..
[190]
Nordmann AJ, Woo K, Parkes R, Logan AG..
Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis?. A metaanalysis of randomized controlled trials..
Am J Med. , 114 (2003), pp. 44-50
[191]
Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, et-al..
Revascularization versus medical therapy for renal-artery stenosis..
N Engl J Med. , 361 (2009), pp. 1953-1962
[192]
Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009; 150:840-8, W150-W841..
[193]
Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, et-al..
The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease..
Catheter Cardiovasc Interv. , 75 (2010), pp. 1-10
[194]
Krishnamurthi V, Novick AC, Myles JL..
Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis..
J Urol. , 161 (1999), pp. 1093-1096
[195]
Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, et-al..
Cholesterol crystal embolism: a recognizable cause of renal disease..
Am J Kidney Dis. , 36 (2000), pp. 1089-1109
[196]
Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, et-al..
Embolic protection and platelet inhibition during renal artery stenting..
Circulation. , 117 (2008), pp. 2752-2760
[197]
Bloch MJ, Trost DW, Pickering TG, Sos TA, August P..
Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement..
Am J Hypertens. , 12 (1999), pp. 1-7
[198]
Symonides B, Chodakowska J, Januszewicz A, Lapinski M, Januszewicz M, Rowinski O, et-al..
Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology..
Blood Press. , 8 (1999), pp. 141-150
[199]
Zeller T, Rastan A, Schwarzwalder U, Muller C, Frank U, Burgelin K, et-al..
Regression of left ventricular hypertrophy following stenting of renal artery stenosis..
[200]
Schwarzwalder U, Hauk M, Zeller T..
RADAR—a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis..
[201]
Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, et-al..
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia..
N Engl J Med. , 309 (1983), pp. 274-279
[202]
Slovut DP, Olin JW..
Fibromuscular dysplasia..
N Engl J Med. , 350 (2004), pp. 1862-1871
[203]
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB..
The longterm outcomes of percutaneous therapy for renal artery fibromuscular dysplasia..
J Vasc Surg. , 48 (2008), pp. 865-871
[204]
Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF..
Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis..
Hypertension. , 56 (2010), pp. 525-532
[205]
Van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, et-al..
Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial..
Lancet. , 353 (1999), pp. 282-286
[206]
Rastan A, Krankenberg H, Muller-Hulsbeck S, Sixt S, Tubler T, Muller C, et-al..
Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION)..
EuroIntervention. , 4 (2008), pp. 208-213
[207]
Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ..
Primary renal artery stenting: characteristics and outcomes after 363 procedures..
Am Heart J. , 142 (2001), pp. 314-323
[208]
Zahringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, et-al..
Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years..
[209]
Misra S, Thatipelli MR, Howe PW, Hunt C, Mathew V, Barsness GW, et-al..
Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller..
J Vasc Interv Radiol. , 19 (2008), pp. 833-839
[210]
Zeller T, Rastan A, Schwarzwalder U, Mueller C, Schwarz T, Frank U, et-al..
Treatment of instent restenosis following stent-supported renal artery angioplasty..
Catheter Cardiovasc Interv. , 70 (2007), pp. 454-459
[211]
N’Dandu ZM, Badawi RA, White CJ, Grise MA, Reilly JP, Jenkins JS, et-al..
Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone..
Catheter Cardiovasc Interv. , 71 (2008), pp. 701-705
[212]
Patel PM, Eisenberg J, Islam MA, Maree AO, Rosenfield KA..
Percutaneous revascularization of persistent renal artery in-stent restenosis..
Vasc Med. , 14 (2009), pp. 259-264
[213]
Davies MG, Saad WA, Bismuth JX, Peden EK, Naoum JJ, Lumsden AB..
Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting..
J Vasc Surg. , 49 (2009), pp. 946-952
[214]
Novick AC, Ziegelbaum M, Vidt DG, Gifford RW, Pohl MA, Goormastic M..
Trends in surgical revascularization for renal artery disease. Ten years’ experience..
JAMA. , 257 (1987), pp. 498-501
[215]
Clair DG, Belkin M, Whittemore AD, Mannick JA, Donaldson MC..
Safety and efficacy of transaortic renal endarterectomy as an adjunct to aortic surgery..
J Vasc Surg. , 21 (1995), pp. 926-933
[216]
Cambria RP, Brewster DC, L’Italien GJ, Moncure A, Darling RC, Gertler JP, et-al..
The durability of different reconstructive techniques for atherosclerotic renal artery disease..
J Vasc Surg. , 20 (1994), pp. 76-85
[217]
Senekowitsch C, Assadian A, Wlk MV, Assadian O, Ptakovsky H, Hagmuller GW..
Renal artery surgery in the era of endovascular intervention..
Vasa. , 33 (2004), pp. 226-230
[218]
Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Modder U, Godehardt E, et-al..
Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD)..
J Vasc Surg. , 49 (2009), pp. 667-674
[219]
Hollenberg NK..
Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients..
Cardiovasc Rev Rep. , 4 (1983), pp. 852-876
[220]
Dorros G, Prince C, Mathiak L..
Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty..
Cathet Cardiovasc Diagn. , 29 (1993), pp. 191-198
[221]
Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Horn B, et-al..
Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions..
J Endovasc Ther. , 11 (2004), pp. 95-106
[222]
Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP, et-al..
Predictors of improved renal function after percutaneous stentsupported angioplasty of severe atherosclerotic ostial renal artery stenosis..
Circulation. , 108 (2003), pp. 2244-2249
[223]
Korsakas S, Mohaupt MG, Dinkel HP, Mahler F, Do DD, Voegele J, et-al..
Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions..
Kidney Int. , 65 (2004), pp. 251-258
[224]
Leng GC, Fowkes FG..
The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys..
J Clin Epidemiol. , 45 (1992), pp. 1101-1109
[225]
McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et-al..
Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment..
JAMA. , 286 (2001), pp. 1599-1606
[226]
Lijmer JG, Hunink MG, Van den Dungen JJ, Loonstra J, Smit AJ..
ROC analysis of noninvasive tests for peripheral arterial disease..
Ultrasound Med Biol. , 22 (1996), pp. 391-398
[227]
Stoffers HE, Kester AD, Kaiser V, Rinkens PE, Kitslaar PJ, Knottnerus JA..
The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care..
J Clin Epidemiol. , 49 (1996), pp. 1401-1405
[228]
Baker JD, Dix DE..
Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial-ankle pressure gradient..
Surgery. , 89 (1981), pp. 134-137
[229]
Schroder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, et-al..
A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease..
J Vasc Surg. , 44 (2006), pp. 531-536
[230]
Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW..
Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease..
Vasc Med. , 11 (2006), pp. 29-33
[231]
Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, Criqui MH..
The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects..
J Vasc Surg. , 48 (2008), pp. 1197-1203
[232]
Hiatt WR, Cox L, Greenwalt M, Griffin A, Schechter C..
Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials..
Vasc Med. , 10 (2005), pp. 207-213
[233]
Ouriel K, McDonnell AE, Metz CE, Zarins CK..
Critical evaluation of stress testing in the diagnosis of peripheral vascular disease..
Surgery. , 91 (1982), pp. 686-693
[234]
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31:S1-296..
[235]
Regensteiner JG, Gardner A, Hiatt WR..
Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997..
Vasc Med. , 2 (1997), pp. 147-155
[236]
Koelemay MJ, Den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ..
Diagnosis of arterial disease of the lower extremities with duplex ultrasonography..
Br J Surg. , 83 (1996), pp. 404-409
[237]
Visser K, Hunink MG..
Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis..
[238]
Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007; 11:iii-iv, xi-xiii, 1-184..
[239]
Winter-Warnars HA, Van der Graaf Y, Mali WP..
Interobserver variation in duplex sonographic scanning in the femoropopliteal tract..
J Ultrasound Med. , 15 (1996), pp. 421-428
[240]
Koelemay MJ, Legemate DA, Van Gurp JA, De Vos H, Balm R, Jacobs MJ..
Interobserver variation of colour duplex scanning of the popliteal, tibial and pedal arteries..
Eur J Vasc Endovasc Surg. , 21 (2001), pp. 160-164
[241]
Bandyk DF, Chauvapun JP..
Duplex ultrasound surveillance can be worthwhile after arterial intervention..
Perspect Vasc Surg Endovasc Ther. , 19 (2007), pp. 354-359
[242]
Ferris BL, Mills JL, Hughes JD, Durrani T, Knox R..
Is early postoperative duplex scan surveillance of leg bypass grafts clinically important?..
J Vasc Surg. , 37 (2003), pp. 495-500
[243]
Ouwendijk R, De Vries M, Stijnen T, Pattynama PM, Van Sambeek MR, Buth J, et-al..
Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial..
AJR Am J Roentgenol. , 190 (2008), pp. 1349-1357
[244]
Hingorani A, Ascher E, Marks N..
Preprocedural imaging: new options to reduce need for contrast angiography..
Semin Vasc Surg. , 20 (2007), pp. 15-28
[245]
Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ..
Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis..
JAMA. , 301 (2009), pp. 415-424
[246]
Poon E, Yucel EK, Pagan-Marin H, Kayne H..
Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography..
AJR Am J Roentgenol. , 169 (1997), pp. 1139-1144
[247]
Ho KY, De Haan MW, Kessels AG, Kitslaar PJ, Van Engelshoven JM..
Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography..
Radiology. , 206 (1998), pp. 673-681
[248]
Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J..
Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography..
Radiology. , 206 (1998), pp. 693-701
[249]
Nelemans PJ, Leiner T, De Vet HC, Van Engelshoven JM..
Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography..
Radiology. , 217 (2000), pp. 105-114
[250]
Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM..
Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a metaanalysis..
JAMA. , 285 (2001), pp. 1338-1345
[251]
Barnes RW..
Noninvasive diagnostic assessment of peripheral vascular disease..
Circulation. , 83 (1991), pp. I20-I27
[252]
Clement DL, Van Maele GO, De Pue NY..
Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs..
Int Angiol. , 4 (1985), pp. 69-74
[253]
Watson L, Ellis B, Leng GC..
Exercise for intermittent claudication..
Cochrane Database Syst Rev. , (2008), pp. CD000990
[254]
Gardner AW, Poehlman ET..
Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis..
JAMA. , 274 (1995), pp. 975-980
[255]
Bendermacher BL, Willigendael EM, Teijink JA, Prins MH..
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication..
Cochrane Database Syst Rev. , (2006), pp. CD005263
[256]
Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG..
Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response..
Circulation. , 90 (1994), pp. 1866-1874
[257]
Hodges LD, Sandercock GR, Das SK, Brodie DA..
Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease..
Clin Physiol Funct Imaging. , 28 (2008), pp. 32-37
[258]
Claeys R, Bogaert M, Clement D..
Study on the non-drug, conservative treatment of intermittent claudication..
T Geneeskunde. , 38 (1982), pp. 585-588
[259]
Treat-Jacobson D, Bronas UG, Leon AS..
Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication..
Vasc Med. , 14 (2009), pp. 203-213
[260]
Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA, McDermott M..
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication..
Vasc Med. , 15 (2010), pp. 181-188
[261]
Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, et-al..
Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies..
Eur J Vasc Endovasc Surg. , 38 (2009), pp. 463-474
[262]
O’Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV..
The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease..
J Vasc Surg. , 49 (2009), pp. 1226-1234
[263]
Lehert P, Comte S, Gamand S, Brown TM..
Naftidrofuryl in intermittent claudication: a retrospective analysis..
J Cardiovasc Pharmacol. , 23 (1994), pp. S48-S52
[264]
De Backer T, Vander Stichele R, Lehert P, Van Bortel L..
Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data..
BMJ. , 338 (2009), pp. b603
[265]
Spengel F, Clement D, Boccalon H, Liard F, Brown T, Lehert P..
Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program..
Int Angiol. , 21 (2002), pp. 20-27
[266]
Brevetti G, Diehm C, Lambert D..
European multicenter study on propionyl-Lcarnitine in intermittent claudication..
J Am Coll Cardiol. , 34 (1999), pp. 1618-1624
[267]
Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, et-al..
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication..
Am J Med. , 110 (2001), pp. 616-622
[268]
Leizorovicz A, Becker F..
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebocontrolled, 4-year study..
Circulation. , 117 (2008), pp. 816-822
[269]
De Backer TL, Bogaert M, Vander Stichele R..
Buflomedil for intermittent claudication..
Cochrane Database Syst Rev. , (2008), pp. CD000988
[270]
De Backer TL, Vander Stichele RH, Van Bortel LM..
Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication..
Drug Saf. , 32 (2009), pp. 283-291
[271]
De Buyzere ML, Clement DL..
Management of hypertension in peripheral arterial disease..
Prog Cardiovasc Dis. , 50 (2008), pp. 238-263
[272]
Shahin Y, Mazari F, Chetter I..
Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease?. A systematic review and meta-analysis of randomised controlled trials..
Int J Surg. , 9 (2011), pp. 209-213
[273]
Bogaert MG, Clement DL..
Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication..
Eur Heart J. , 4 (1983), pp. 203-204
[274]
Paravastu SC, Mendonca DA, Da Silva A..
Beta blockers for peripheral arterial disease..
Eur J Vasc Endovasc Surg. , 38 (2009), pp. 66-70
[275]
Nicolai SP, Kruidenier LM, Bendermacher BL, Prins MH, Teijink JA..
Ginkgo biloba for intermittent claudication..
Cochrane Database Syst Rev. , (2009),
[276]
Labropoulos N, Wierks C, Suffoletto B..
Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review..
Vasc Med. , 7 (2002), pp. 141-148
[277]
De Haro J, Acin F, Florez A, Bleda S, Fernandez JL..
A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication..
J Vasc Surg. , 51 (2010), pp. 857-862
[278]
Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, et-al..
A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries..
Eur Heart J. , 28 (2007), pp. 798-805
[279]
Spronk S, Bosch JL, Den Hoed PT, Veen HF, Pattynama PM, Hunink MG..
Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial..
Radiology. , 250 (2009), pp. 586-595
[280]
Klein WM, Van der Graaf Y, Seegers J, Moll FL, Mali WP..
Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study..
Radiology. , 232 (2004), pp. 491-498
[281]
Bosch JL, Hunink MG..
Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease..
Radiology. , 204 (1997), pp. 87-96
[282]
Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O’Hara PJ, Lyden SP, et-al..
The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction..
J Vasc Surg. , 48 (2008), pp. 1451-1457
[283]
Grenacher L, Rohde S, Ganger E, Deutsch J, Kauffmann GW, Richter GM..
In vitro comparison of self-expanding versus balloon-expandable stents in a human ex vivo model..
Cardiovasc Intervent Radiol. , 29 (2006), pp. 249-254
[284]
Tetteroo E, Van der Graaf Y, Bosch JL, Van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153-9..
[285]
Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et-al..
Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting..
Circulation. , 115 (2007), pp. 2745-2749
[286]
Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et-al..
Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions..
Catheter Cardiovasc Interv. , 74 (2009), pp. 1090-1095
[287]
Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, et-al..
Prevalence and clinical impact of stent fractures after femoropopliteal stenting..
J Am Coll Cardiol. , 45 (2005), pp. 312-315
[288]
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et-al..
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial..
J Endovasc Ther. , 13 (2006), pp. 701-710
[289]
Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, et-al..
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg..
N Engl J Med. , 358 (2008), pp. 689-699
[290]
Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D..
Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral- popliteal bypass in the treatment of superficial femoral arterial occlusive disease..
J Vasc Surg. , 45 (2007), pp. 10-16
[291]
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et-al, RESILIENT investigators..
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelvemonth results from the RESILIENT randomized trial..
Circ Cardiovasc Interv. , 3 (2010), pp. 267-276
[292]
Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C, Assaloni R, et-al..
Longterm outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia..
Eur J Vasc Endovasc Surg. , 37 (2009), pp. 336-342
[293]
Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ, et-al..
Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease..
J Vasc Surg. , 50 (2009), pp. 799-805
[294]
Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, et-al..
Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome..
J Vasc Interv Radiol. , 20 (2009), pp. 1141-1150
[295]
Chiu KW, Davies RS, Nightingale PG, Bradbury AW, Adam DJ..
Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease..
Eur J Vasc Endovasc Surg. , 39 (2010), pp. 460-471
[296]
Twine CP, McLain AD..
Graft type for femoro-popliteal bypass surgery..
Cochrane Database Syst Rev. , (2010), pp. CD001487
[297]
Griffiths GD, Nagy J, Black D, Stonebridge PA..
Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting..
Br J Surg. , 91 (2004), pp. 560-562
[298]
SCAMICO S..
PTFE bypass to below-knee arteries: distal vein collar or not?. A prospective randomised multicentre study..
Eur J Vasc Endovasc Surg. , 39 (2010), pp. 747-754
[299]
Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T..
A contemporary metaanalysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting..
J Vasc Surg. , 52 (2010), pp. 232-236
[300]
Johnson WC, Lee KK..
A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal aboveknee revascularization: a prospective randomized Department of Veterans Affairs cooperative study..
J Vasc Surg. , 32 (2000), pp. 268-277
[301]
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et-al, BASIL TrialParticipants..
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplastyfirst revascularization strategy..
J Vasc Surg. , 51 (2010), pp. S5-S17
[302]
Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et-al..
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial..
Lancet. , 366 (2005), pp. 1925-1934
[303]
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et-al..
BASIL TrialParticipants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making..
J Vasc Surg. , 51 (2010), pp. S52-S68
[304]
Diehm N, Schillinger M, Minar E, Gretener S, Baumgartner I..
TASC II section E3 on the treatment of acute limb ischemia: commentary from European interventionists..
J Endovasc Ther. , 15 (2008), pp. 126-128
[305]
Bandyk DF..
Surveillance after lower extremity arterial bypass..
Perspect Vasc Surg Endovasc Ther. , 19 (2007), pp. 376-383
[306]
Davies AH, Hawdon AJ, Sydes MR, Thompson SG, VGSTParticipants..
Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST)..
Circulation. , 112 (2005), pp. 1985-1991
[307]
Brumberg RS, Back MR, Armstrong PA, Cuthbertson D, Shames ML, Johnson BL, et-al..
The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure..
J Vasc Surg. , 46 (2007), pp. 1160-1166
[308]
Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH..
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery..
Cochrane Database Syst Rev. , (2008), pp. CD000535
[309]
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet. 2000; 355:346-51..
[310]
Johnson WC, Williford WO..
Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study..
J Vasc Surg. , 35 (2002), pp. 413-421
[311]
Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, et-al..
Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure..
J Vasc Surg. , 28 (1998), pp. 446-457
[312]
Belch JJ, Dormandy J; CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010; 52:825-33, 833.e821-2..
[313]
Dagher NN, Modrall JG..
Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins..
Semin Vasc Surg. , 20 (2007), pp. 10-14
[314]
Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et-al..
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial..
Lancet. , 360 (2002), pp. 427-435
[315]
Kusumanto YH, Van Weel V, Mulder NH, Smit AJ, Van den Dungen JJ, Hooymans JM, et-al..
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial..
Hum Gene Ther. , 17 (2006), pp. 683-691
[316]
Nikol S, Baumgartner I, Van Belle E, Diehm C, Visona A, Capogrossi MC, et-al..
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia..
Mol Ther. , 16 (2008), pp. 972-978
[317]
Shigematsu H, Yasuda K, Iwai T, Sasajima T, Ishimaru S, Ohashi Y, et-al..
Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia..
Gene Ther. , 17 (2010), pp. 1152-1161
[318]
Rajagopalan S, Mohler ER, 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, et-al..
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication..
Circulation. , 108 (2003), pp. 1933-1938
[319]
Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, et-al..
Results from a phase II multicenter, double-blind placebocontrolled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease..
Am Heart J. , 153 (2007), pp. 874-880
[320]
Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC..
Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrowmononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans..
Thromb Haemost. , 98 (2007), pp. 1335-1342
[321]
Sprengers RW, Moll FL, Verhaar MC..
Stem cell therapy in PAD..
Eur J Vasc Endovasc Surg. , 39 (2010), pp. S38-S43
[322]
Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, et al; on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebocontrolled trial of gene therapy in critical limb ischaemia. Lancet. 2011; 377:1929-37..
[323]
Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et-al..
Is intermittent claudication improved by percutaneous transluminal angioplasty?. A randomized controlled trial..
J Vasc Surg. , 26 (1997), pp. 551-557
[324]
Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et-al..
The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease..
Eur J Vasc Endovasc Surg. , 36 (2008), pp. 680-688
[325]
Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, et-al, CLEVER Steering Committee..
The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods..
J Vasc Surg. , 47 (2008), pp. 1356-1363
[326]
Diehm C, Lange S, Darius H, Pittrow D, Von Stritzky B, Tepohl G, et-al..
Association of low ankle brachial index with high mortality in primary care..
Eur Heart J. , 27 (2006), pp. 1743-1749
[327]
Slovut DP, Sullivan TM..
Critical limb ischemia: medical and surgical management..
Vasc Med. , 13 (2008), pp. 281-291
[328]
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et-al..
Recommended standards for reports dealing with lower extremity ischemia: revised version..
J Vasc Surg. , 26 (1997), pp. 517-538
[329]
Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45:645-54..
[330]
Catalano M, Born G, Peto R..
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial..
J Intern Med. , 261 (2007), pp. 276-284
[331]
Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I..
Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome..
J Vasc Surg. , 45 (2007), pp. 751-761
[332]
Lawrence PF, Chandra A..
When should open surgery be the initial option for critical limb ischaemia?..
Eur J Vasc Endovasc Surg. , 39 (2010), pp. S32-S37
[333]
Van Damme H, Zhang L, Baguet E, Creemers E, Albert A, Limet R..
Crural artery bypass with the autogenous greater saphenous vein..
Eur J Vasc Endovasc Surg. , 26 (2003), pp. 635-642
[334]
Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR, et-al..
A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases..
J Vasc Surg. , 37 (2003), pp. 307-315
[335]
Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, et-al..
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia..
J Vasc Surg. , 50 (2009), pp. 1462-1473
[336]
Wolfe JH, Wyatt MG..
Critical and subcritical ischaemia..
Eur J Vasc Endovasc Surg. , 13 (1997), pp. 578-582
[337]
Taylor SM, Cull DL, Kalbaugh CA, Cass AL, Harmon SA, Langan EM, et-al..
Critical analysis of clinical success after surgical bypass for lowerextremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment..
J Am Coll Surg. , 204 (2007), pp. 831-838
[338]
Dormandy JA..
Prostanoid drug therapy for peripheral arterial occlusive disease— the European experience..
Vasc Med. , 1 (1996), pp. 155-158
[339]
Creutzig A, LehmacherW, Elze M..
Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV..
Vasa. , 33 (2004), pp. 137-144
[340]
Ruffolo AJ, Romano M, Ciapponi A..
Prostanoids for critical limb ischaemia..
Cochrane Database Syst Rev. , (2010), pp. CD006544
[341]
Ubbink DT, Vermeulen H..
Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia..
Cochrane Database Syst Rev. , (2005), pp. CD004001
[342]
Sobel M, Verhaeghe R..
Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)..
Chest. , 133 (2008), pp. S815-S843
[343]
Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, et-al..
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia..
J Vasc Surg. , 19 (1994), pp. 1021-1030
[344]
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994; 220:251-66..
[345]
Ouriel K, Veith FJ, Sasahara AA, Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators..
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs..
N Engl J Med. , 338 (1998), pp. 1105-1111
[346]
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et-al..
Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)..
Eur Heart J. , 31 (2010), pp. 2501-2555
[347]
Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB..
Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study..
Am Heart J. , 125 (1993), pp. 863-872
[348]
Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Rother J, et-al, REduction of Atherothrombosis for Continued Health Registry Investigators..
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry..
Eur Heart J. , 30 (2009), pp. 2318-2326
[349]
Ferrieres J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A..
Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting..
Int J Cardiol. , 112 (2006), pp. 302-307
[350]
Aboyans V, Lacroix P..
Indications for carotid screening in patients with coronary artery disease..
Presse Med. , 38 (2009), pp. 977-986
[351]
Blacker DJ, Flemming KD, Link MJ, Brown RD..
The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery..
Mayo Clin Proc. , 79 (2004), pp. 223-229
[352]
Aboyans V, Lacroix P, Guilloux J, Rolle F, Le Guyader A, Cautres M, et-al..
A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting..
Interact Cardiovasc Thorac Surg. , 4 (2005), pp. 90-95
[353]
Brown KR, Kresowik TF, Chin MH, Kresowik RA, Grund SL, Hendel ME..
Multistate population-based outcomes of combined carotid endarterectomy and coronary artery bypass..
J Vasc Surg. , 37 (2003), pp. 32-39
[354]
Selim M..
Perioperative stroke..
N Engl J Med. , 356 (2007), pp. 706-713
[355]
Naylor R, Cuffe RL, Rothwell PM, Loftus IM, Bell PR..
A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: influence of surgical and patient variables..
Eur J Vasc Endovasc Surg. , 26 (2003), pp. 230-241
[356]
Kolh PH, Comte L, Tchana-Sato V, Honore C, Kerzmann A, Mauer M, et-al..
Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results..
Eur Heart J. , 27 (2006), pp. 49-56
[357]
Hill MD, Shrive FM, Kennedy J, Feasby TE, Ghali WA..
Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada..
Neurology. , 64 (2005), pp. 1435-1437
[358]
Dubinsky RM, Lai SM..
Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US..
[359]
Byrne J, Darling RC, 3rd, Roddy SP, Mehta M, Paty PS, Kreienberg PB, et-al..
Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures..
J Vasc Surg. , 44 (2006), pp. 67-72
[360]
Char D, Cuadra S, Ricotta J, Bilfinger T, Giron F, McLarty A, et-al..
Combined coronary artery bypass and carotid endarterectomy: long-term results..
Cardiovasc Surg. , 10 (2002), pp. 111-115
[361]
Cywinski JB, Koch CG, Krajewski LP, Smedira N, Li L, Starr NJ..
Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery..
J Cardiothorac Vasc Anesth. , 20 (2006), pp. 796-802
[362]
Ricotta JJ, Wall LP, Blackstone E..
The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study..
J Vasc Surg. , 41 (2005), pp. 397-401
[363]
Timaran CH, Rosero EB, Smith ST, Valentine RJ, Modrall JG, Clagett GP..
Trends and outcomes of concurrent carotid revascularization and coronary bypass..
J Vasc Surg. , 48 (2008), pp. 355-361
[364]
Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, et-al..
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure)..
Am J Cardiol. , 96 (2005), pp. 519-523
[365]
Kovacic JC, Roy PR, Baron DW, Muller DW..
Staged carotid artery stenting and coronary artery bypass graft surgery: initial results from a single center..
Catheter Cardiovasc Interv. , 67 (2006), pp. 142-148
[366]
Randall MS, McKevitt FM, Cleveland TJ, Gaines PA, Venables GS..
Is there any benefit from staged carotid and coronary revascularization using carotid stents?. A single-center experience highlights the need for a randomized controlled trial..
[367]
Mendiz O, Fava C, Valdivieso L, Dulbecco E, Raffaelli H, Lev G, et-al..
Synchronous carotid stenting and cardiac surgery: an initial single-center experience..
Catheter Cardiovasc Interv. , 68 (2006), pp. 424-428
[368]
Van der Heyden J, Suttorp MJ, Bal ET, Ernst JM, Ackerstaff RG, Schaap J, et-al..
Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results..
Circulation. , 116 (2007), pp. 2036-2042
[369]
Ghosh J, Murray D, Khwaja N, Murphy MO, Walker MG..
The influence of asymptomatic significant carotid disease on mortality and morbidity in patients undergoing coronary artery bypass surgery..
Eur J Vasc Endovasc Surg. , 29 (2005), pp. 88-90
[370]
Naylor AR, Mehta Z, Rothwell PM..
A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass..
Eur J Vasc Endovasc Surg. , 37 (2009), pp. 379-387
[371]
Van der Heyden J, Lans HW, Van Werkum JW, Schepens M, Ackerstaff RG, Suttorp MJ..
Will carotid angioplasty become the preferred alternative to staged or synchronous carotid endarterectomy in patients undergoing cardiac surgery?..
Eur J Vasc Endovasc Surg. , 36 (2008), pp. 379-384
[372]
Guzman LA, Costa MA, Angiolillo DJ, Zenni M, Wludyka P, Silliman S, et-al..
A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery..
Stroke. , 39 (2008), pp. 361-365
[373]
Wiesmann M, Schopf V, Jansen O, Bruckmann H..
Stent-protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: metaanalysis of randomized trial data..
Eur Radiol. , 18 (2008), pp. 2956-2966
[374]
Versaci F, Reimers B, Del Giudice C, Schofer J, Giacomin A, Sacca S, et-al..
Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study..
JACC Cardiovasc Interv. , 2 (2009), pp. 393-401
[375]
Park S, Jung JH, Seo HS, Ko YG, Choi D, Jang Y, et-al..
The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography..
Heart Vessels. , 19 (2004), pp. 275-279
[376]
Zhang Y, Ge JB, Qian JY, Ye ZB..
Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200 Chinese patients undergoing coronary angiography..
Nephron Clin Pract. , 104 (2006), pp. c185-c192
[377]
Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et-al..
Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization..
J Am Soc Nephrol. , 2 (1992), pp. 1608-1616
[378]
Gross CM, Kramer J, Waigand J, Luft FC, Dietz R..
Relation between arteriosclerosis in the coronary and renal arteries..
Am J Cardiol. , 80 (1997), pp. 1478-1481
[379]
Przewlocki T, Kablak-Ziembicka A, Tracz W, Kozanecki A, Kopec G, Rubis P, et-al..
Renal artery stenosis in patients with coronary artery disease..
Kardiol Pol. , 66 (2008), pp. 856-862
[380]
Tumelero RT, Duda NT, Tognon AP, Thiesen M..
Prevalence of renal artery stenosis in 1,656 patients who have undergone cardiac catheterization..
Arq Bras Cardiol. , 87 (2006), pp. 248-253
[381]
Kownator S, Cambou JP, Cacoub P, Leger P, Luizy F, Herrmann MA, et-al..
Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study..
Arch Cardiovasc Dis. , 102 (2009), pp. 625-631
[382]
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et-al..
Peripheral arterial disease detection, awareness, and treatment in primary care..
JAMA. , 286 (2001), pp. 1317-1324
[383]
Agnelli G, Cimminiello C, Meneghetti G, Urbinati S..
Polyvascular Atherothrombosis Observational Survey Investigators. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events..
J Thromb Haemost. , 4 (2006), pp. 2599-2606
[384]
Poredos P, Jug B..
The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients..
Angiology. , 58 (2007), pp. 309-315
[385]
Hayoz D, Bounameaux H, Canova CR..
Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease..
J Intern Med. , 258 (2005), pp. 238-243
[386]
Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ..
Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators..
J Am Coll Cardiol. , 23 (1994), pp. 1091-1095
[387]
Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U. Short- and longterm prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med. 1994; 96:15-9..
[388]
Makowsky MJ, McAlister FA, Galbraith PD, Southern DA, Ghali WA, Knudtson ML, et-al, Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators..
Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy..
Am Heart J. , 155 (2008), pp. 348-355
[389]
Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M..
Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy..
Atherosclerosis. , 175 (2004), pp. 131-138
[390]
Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, et-al..
Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)..
Am J Cardiol. , 100 (2007), pp. 1-6
[391]
Leger P, Ferrieres J, Cantie P, Cambou JP, Ruidavets JB, Tarabbia P, et-al..
Chronic obliterative arterial disease of the lower limbs in the coronary patient: prevalence and prognostic incidence The Monica Toulouse register..
Rev Med Interne. , 20 (1999), pp. 404-407
[392]
Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, et-al..
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials..
J Am Coll Cardiol. , 48 (2006), pp. 1567-1572
[393]
Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, et-al..
Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation..
Circulation. , 100 (1999), pp. 171-177
[394]
Aboyans V, Lacroix P, Postil A, Guilloux J, Rolle F, Cornu E, et-al..
Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting..
J Am Coll Cardiol. , 46 (2005), pp. 815-820
[395]
Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, et-al..
Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study..
J Am Coll Cardiol. , 54 (2009), pp. 989-996
[396]
McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et-al..
Coronaryartery revascularization before elective major vascular surgery..
N Engl J Med. , 351 (2004), pp. 2795-2804
[397]
Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, et al; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007; 49:1763-9..
[398]
Hertzer NR, Young JR, Beven EG, Graor RA, O’Hara PJ, Ruschhaupt WF, et-al..
Coronary angiography in 506 patients with extracranial cerebrovascular disease..
Arch Intern Med. , 145 (1985), pp. 849-852
[399]
Hofmann R, Kypta A, Steinwender C, Kerschner K, Grund M, Leisch F..
Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease..
Heart. , 91 (2005), pp. 1438-1441
[400]
Illuminati G, Ricco JB, Greco C, Mangieri E, Calio F, Ceccanei G, et-al..
Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial..
Eur J Vasc Endovasc Surg. , 39 (2010), pp. 139-145
[401]
Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt WF, Graor RA, et-al..
Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management..
Ann Surg. , 199 (1984), pp. 223-233
[402]
Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et-al, REACH REGISTRY Investigators..
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis..
JAMA. , 295 (2006), pp. 180-189
[403]
Aronow WS, Ahn C..
Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women >or=62 years of age..
Am J Cardiol. , 74 (1994), pp. 64-65
[404]
Ness J, Aronow WS..
Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice..
J Am Geriatr Soc. , 47 (1999), pp. 1255-1256
[405]
Lange S, Trampisch HJ, Haberl R, Darius H, Pittrow D, Schuster A, et-al..
Excess 1-year cardiovascular risk in elderly primary care patients with a low anklebrachial index (ABI) and high homocysteine level..
Atherosclerosis. , 178 (2005), pp. 351-357
[406]
Bhatt D, Eagle K, Ohman EM, Hirsch AT, Goto S, Wislon PFW, et-al..
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis..
JAMA. , 304 (2010), pp. 1350-1357
[407]
Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356:1503-16..
Idiomas
Revista Española de Cardiología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?